- NVAX +98.66%
Novavax Inc (NVAX) (Q1 2024) Earnings Call Transcript Highlights: Strategic Partnerships and ...
Yahoo Finance · 2 hours ago
Open | 10.02 |
High | 11.00 |
Low | 8.61 |
Mkt Cap | 1.25B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 4.47 |
52 Wk. Low | 3.53 |
52 Wk. High | 11.00 |
Related stocks
Company in Gaithersburg, Maryland
Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 93.86M | 15.90% ▲ |
Net Income | -147.55M | - |
Diluted EPS | -1.44 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q1 2024 | -$1.06 | - |
Q4 2023 | -$0.45 | -$1.44 |
Q3 2023 | -$1.83 | -$1.26 |
S&P FuturesES=F | 5,250.25+4.00 (+0.08%) |
Dow FuturesYM=F | 39,653.00+11.00 (+0.03%) |
Nasdaq FuturesNQ=F | 18,280.25+25.25 (+0.14%) |
81.150+4.11% | |
Tata Motors LimitedTATAMOTORS.NS | 959.95-8.28% |
Oklo Inc.OKLO | 8.45-53.65% |